BRAINCURES LTD

Biological intelligence (BI): a biology first approach that de-risks and accelerates preclinical and clinical drug discovery and development without deep learning steps associated with artificial intelligence (AI).
Learn more about #BiologicalIntelligence➡️linkedin.com/pulse/biologic…

BRAINCURES turns outputs from @OpenTargets and @InSilicoMeds' TargetBench Platforms into high success preclinical and clinical investments. Of note, TargetBench version 2.0 seems to have lost the disease gene list feature present in TargetBench version 1.0
linkedin.com/feed/update/ur…

🧵To mark World Alzheimer's Month, we present how our foundation model can navigate over 270 thousand Alzheimer's linked publications to identify and prioritize highly networked hub targets that carry high predicted preclinical/clinical success rates. See lnkd.in/eHCnfAvZ

linkedin.com/posts/how-to-v… highlights how BRAINCURES @BraincuresLTD's synaptic plasticity powered foundation model can turn Insilico Medicine @InSilicoMeds' TargetBench outputs for Parkinson's disease into actionable intelligence for high success preclinical and clinical investment

🧵Altered hippocampal LTP/LTD is a major driver in aging. BRAINCURES' prioritization of age-associated gene expression in the human and rat dentate gyrus reveals 17 highly novel human-rat synaptic plasticity targets for brain health and healthy longevity
linkedin.com/posts/braincur…